Creo Medical Europe

Creo Medical Europe is a medical device company focused on developing and commercializing minimally invasive electrosurgical devices for therapeutic endoscopy. Founded in 2003 by Professor Chris Hancock, the company initially specialized in high-frequency microwave energy for cancer treatment before rebranding as Creo Medical in 2010 to broaden its medical device portfolio. The company's core innovation is the CROMA Advanced Energy platform, which utilizes proprietary Kamaptive Technology for precision surgical procedures. Creo Medical offers a range of products categorized into resection, ablation, diagnostics, therapeutics, and hygiene. Notably, in 2025, they launched the SpydrBlade Flex, a versatile endoscopic device designed for enhanced precision in surgeries. Creo Medical serves healthcare professionals and hospitals globally, partnering with clinicians to facilitate the transition from traditional surgical methods to therapeutic endoscopy. Under CEO Craig Gulliford's leadership since 2012, the company has expanded its international presence and product pipeline, emphasizing innovation and quality in its offerings.

• Employees 24
• Founded 1985